aVaxMed

aVaxMed Limited is a UK biotech developing the aVaxziPen platform, a proprietary needle-free, thermally stable, solid dose vaccine delivery system.

The technology encapsulates vaccine antigens into unit solid doses administered via a pen applicator, removing the need for needles and reducing cold chain requirements.

The company works with government agencies, global vaccine developers and non-governmental organisations to apply the platform across infectious disease, mRNA and protein-based vaccine programmes.